How Does Cannabis Affect People Diagnosed with Panic Disorder?

PostedMarch 2, 2026

UpdatedMarch 2, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Research into cannabis effects on panic disorder suggests that cannabinoids like CBD may reduce the intensity and frequency of panic attacks. Understanding cannabis effects on panic disorder helps patients and clinicians assess potential benefits, risks, and integration with other therapies. Observing patient response is key to determining the effectiveness of treatment. Early studies indicate that cannabinoid influence may improve emotional regulation and provide symptomatic relief, making it a potential complementary option.

How Cannabis May Impact Panic Disorder

Professional guidance is essential when considering cannabis effects on panic disorder. Monitoring patient response ensures safe use and helps optimise treatment plans. Understanding symptom impact allows clinicians to adjust dosing and evaluate efficacy.

Reduced Panic Episodes

Cannabis may decrease the frequency and severity of panic attacks, giving patients better control over their daily lives.

Anxiety Regulation

Cannabinoids can promote calm and emotional stability, reducing baseline anxiety levels and improving overall symptom impact.

Complementary Therapy

The cannabinoid influence can enhance traditional therapies, supporting improved coping and treatment adherence.

In conclusion, cannabis effects on panic disorder show promise for symptom management when guided by healthcare professionals.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder .

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.